Skip to main content

Search all content

28,300 results sorted by Relevance
  • The Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM) assesses and advises on mutagenic risks to humans. COM is an advisory non-departmental public body, sponsored by the Department of Health and Social Care and the...

  • This series brings together all documents relating to Research case studies

  • Find data and analysis from Census 2021 and earlier censuses.

  • The penalties if you are caught taking or dealing drugs - drug classification, fines and prison sentences

  • Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.

  • Apply for a higher education course, track your application and accept or reject your offers.

  • What intellectual property is, how you can protect it, and which of copyright, patents, design right and trade marks applies to your work

  • Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.

  • This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.

  • Find out how to complete and submit an Other Interest (OI) return using the HMRC spreadsheet or electronic flat text file.

  • Use a separate statement of objection form for each Japanese GI product name you object to.

  • The MHRA is part of the Access Consortium along with the Therapeutic Goods Administration, Health Canada, Health Sciences Authority of Singapore and Swissmedic.

  • The British Film Institute (BFI) is the lead organisation for film in the UK and use Lottery funds to support film production, distribution, education and audience development. Since 1933 they’ve cared for the BFI National Archive, and celebrated the best...

  • It is against the law to discriminate against anyone because of their sex, religion, disability or certain other personal characteristics ('protected characteristics')

  • The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.

  • NHS

    Information from the National Health Service on conditions, treatments, local services and healthy living

  • A collection of guidance about how to protect, manage and enforce copyright. Copyright protects original literary, dramatic, musical and artistic works.

  • How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.

  • Find information and resources for the skills campaigns currently running.